Cancer threat
TWO Fox TV reporters in Tampa, Florida, have reported that Monsanto's gene-tically engineered milk hormone, rBGH (recombinant bovine growth hor-mone), may promote cancer in humans. The milk is sold to dairy farmers, who inject it into their cows every two weeks to increase milk production.
Monsanto and other organisations have documented that rBGH-treated cows undergo several changes: their lives are shortened, they are likely to develop infections and produce milk containing increased levels of another hormone called IGF-l. IGF-1 is associated with increased likelihood of human cancers.
Interestingly, the Food and Drug Administration (PDA) had approved rBGH for use in cows in 1993. However, rBGH was never properly tested by FDA. A standard cancer test of a new human drug requires two years of testing with several hundred rats. But rBGH was tested on 30 rats for only 90 days.
Related Content
- Implementation roadmap for accelerating the prevention and control of noncommunicable diseases in South-East Asia 2022–2030
- Report cites level of cancer threat
- Global status report on alcohol and health 2018
- East Africa to develop policy on aflatoxin to boost food security
- Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016
- Preventing noncommunicable diseases (NCDs) by reducing environmental risk factors